Showing results (71-80 of 89) with videos related to
Sort By:
Pageof 9
Oncotarget|October 6, 2017
Application of 3D tumoroid systems to define immune and cytotoxic therapeutic responses based on tumoroid and tissue slice culture molecular signaturesNiklas K Finnberg, Prashanth Gokare, Avital Lev, et al.Blood Advances|July 24, 2025
HLA-E[pHLA-G] Complex Specific Monoclonal Antibody Enhancing NK Activity in Multiple MyelomaMuhammad Abu Ahmad, Olga Radinsky, Bar Kaufman, et al.Oncotarget|November 19, 2016
An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 alleleCaroline Jochems, James W Hodge, Massimo Fantini, et al.Cancer Medicine|May 16, 2026
Investigating Associations Between Psychological Distress and Changes in Peripheral Blood Monocytes in Patients With CLL/SLL Managed With Active SurveillanceCarolyn Y Fang, Alexander W MacFarlane, Henry C H Fung, et al.Clinical Lymphoma, Myeloma & Leukemia|April 29, 2019
Phase II Study of the PD-1 Inhibitor Pembrolizumab for the Treatment of Relapsed or Refractory Mature T-cell LymphomaStefan K Barta, Jasmine Zain, Alexander W MacFarlane, et al.Cancer Discovery|January 8, 2024
Targeting DHX9 Triggers Tumor-Intrinsic Interferon Response and Replication Stress in Small Cell Lung CancerTakahiko Murayama, Jun Nakayama, Xinpei Jiang, et al.Frontiers in Oncology|February 28, 2022
Tumor-Infiltrating Myeloid Cells Co-Express TREM1 and TREM2 and Elevated TREM-1 Associates With Disease Progression in Renal Cell CarcinomaJill W Ford, Marieli Gonzalez-Cotto, Alexander W MacFarlane, et al.Cancer Prevention Research (Philadelphia, Pa.)|January 7, 2010
Altered gene expression in morphologically normal epithelial cells from heterozygous carriers of BRCA1 or BRCA2 mutationsAlfonso Bellacosa, Andrew K Godwin, Suraj Peri, et al.The Journal of Clinical Investigation|March 14, 2018
Dose intensification of TRAIL-inducing ONC201 inhibits metastasis and promotes intratumoral NK cell recruitmentJessica Wagner, C Leah Kline, Lanlan Zhou, et al.Cancer Biology & Therapy|January 22, 2005
Altered gene expression in phenotypically normal renal cells from carriers of tumor suppressor gene mutationsRadka Stoyanova, Margie L Clapper, Alfonso Bellacosa, et al.Pageof 9